Gilead Sciences

Gilead Sciences, Inc., based in Foster City, California, is an American biopharmaceutical business. Gilead Sciences is a global company with operations across three continents: North America, Europe, and Australia.

After purchasing two smaller pharma businesses that focused on pulmonary illnesses treatment, the international biopharmaceutical company increased its product range after focusing extensively on antiviral medications used in the treatment of HIV, hepatitis B, hepatitis C, and influenza.

Gilead had a sales of $22.1 billion in 2019 and employed 11,800 people. Total revenues for the first quarter of 2020 were $5.5 billion, up 5% from the same period the previous year. This indicates Gilead's continuous success and emphasizes the company's fundamental business's strength. The company's second-quarter 2020 revenue was $5.1 billion, down 10% from $5.7 billion in the same period last year, with Gilead's hepatitis C medicine brand accounting for the majority of the drop. In the third quarter of 2020, total revenues were $6.6 billion, up 17% from $5.6 billion in the same time of 2019.

Founded: June 22, 1987

Headquarters: Foster City, California, United States

Market cap: 84.65B USD

Website: https://www.gilead.com/